These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
428 related items for PubMed ID: 29259513
1. Torsades de Pointes after Ondansetron Infusion in 2 Patients. Lee DY, Trinh T, Roy SK. Tex Heart Inst J; 2017 Oct; 44(5):366-369. PubMed ID: 29259513 [Abstract] [Full Text] [Related]
4. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs). Lu HR, Yan GX, Gallacher DJ. J Pharmacol Toxicol Methods; 2013 Oct; 68(2):250-259. PubMed ID: 23337247 [Abstract] [Full Text] [Related]
5. QT interval prolongation and torsades de pointes due to erythromycin lactobionate. Oberg KC, Bauman JL. Pharmacotherapy; 1995 Oct; 15(6):687-92. PubMed ID: 8602374 [Abstract] [Full Text] [Related]
6. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines. Arbel Y, Swartzon M, Justo D. Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403 [Abstract] [Full Text] [Related]
7. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes. Couderc JP, Kaab S, Hinterseer M, McNitt S, Xia X, Fossa A, Beckmann BM, Polonsky S, Zareba W. J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528 [Abstract] [Full Text] [Related]
8. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes. Tisdale JE, Rasty S, Padhi ID, Sharma ND, Rosman H. J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558 [Abstract] [Full Text] [Related]
15. Female gender does not influence the magnitude of ibutilide-induced repolarization delay and incidence of torsades de pointes in an in vivo rabbit model of the acquired long QT syndrome. Johansson M, Carlsson L. J Cardiovasc Pharmacol Ther; 2001 Jul; 6(3):247-54. PubMed ID: 11584331 [Abstract] [Full Text] [Related]
20. The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis. Abrich VA, Ramakrishna H, Mehta A, Mookadam F, Srivathsan K. Int J Cardiol; 2017 Apr 01; 232():243-246. PubMed ID: 28100427 [Abstract] [Full Text] [Related] Page: [Next] [New Search]